Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Routine invasive strategies compared with conservative strategies do not lower the all-cause mortality in patients with non-ST elevation myocardial infarction and unstable angina.

Thadani U.

Evid Based Med. 2017 Aug 3. pii: ebmed-2016-110527. doi: 10.1136/ebmed-2016-110527. [Epub ahead of print] No abstract available.

PMID:
28775170
2.

Drug Therapy for Stable Angina Pectoris.

Rousan TA, Mathew ST, Thadani U.

Drugs. 2017 Mar;77(3):265-284. doi: 10.1007/s40265-017-0691-7. Review.

PMID:
28120185
3.

The risk of cardiovascular side effects with anti-anginal drugs.

Rousan TA, Mathew ST, Thadani U.

Expert Opin Drug Saf. 2016 Dec;15(12):1609-1623. Epub 2016 Sep 29. Review.

PMID:
27659354
4.

Management of Stable Angina - Current Guidelines: A Critical Appraisal.

Thadani U.

Cardiovasc Drugs Ther. 2016 Aug;30(4):419-26. doi: 10.1007/s10557-016-6681-2. Review.

PMID:
27638354
5.

Invasive strategy in acute coronary syndrome.

Mathew ST, Pakala AV, Thadani U.

Lancet. 2016 Jun 18;387(10037):2503-4. doi: 10.1016/S0140-6736(16)30792-9. No abstract available.

PMID:
27353678
6.

Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.

Patel N, Ju C, Macon C, Thadani U, Schulte PJ, Hernandez AF, Bhatt DL, Butler J, Yancy CW, Fonarow GC.

JACC Heart Fail. 2016 May;4(5):348-56. doi: 10.1016/j.jchf.2015.12.003. Epub 2016 Feb 10.

PMID:
26874392
7.

Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States.

Patel N, Patel NJ, Thakkar B, Singh V, Arora S, Patel N, Savani C, Deshmukh A, Thadani U, Badheka AO, Alfonso C, Fonarow GC, Cohen MG.

Clin Cardiol. 2016 Jan;39(1):9-18. doi: 10.1002/clc.22491.

8.

Percutaneous coronary interventions in the elderly improve quality of life: evidence far from certain.

Thadani U, Latif F.

Cardiology. 2014;129(1):44-5. doi: 10.1159/000364997. Epub 2014 Aug 5. No abstract available.

PMID:
25096401
9.

Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance.

Thadani U.

Am J Cardiovasc Drugs. 2014 Aug;14(4):287-301. doi: 10.1007/s40256-014-0072-5. Review.

PMID:
24664980
10.

Pigment epithelial-derived factor and acute coronary syndrome: a novel protective biomarker but not for routine clinical use at present.

Thadani U, Latif F.

Cardiology. 2014;127(1):28-30. doi: 10.1159/000355453. Epub 2013 Oct 31. No abstract available.

PMID:
24192803
11.

Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.

Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC.

J Am Heart Assoc. 2013 Aug 21;2(4):e000214. doi: 10.1161/JAHA.113.000214.

12.

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ; HF-ACTION Investigators.

Clin Cardiol. 2013 Oct;36(10):611-20. doi: 10.1002/clc.22181. Epub 2013 Aug 8.

13.

Retroperitoneal hemorrhage after cardiac catheterization and percutaneous coronary interventions.

Thadani U, Latif F.

Cardiology. 2013;126(1):24-6. doi: 10.1159/000351977. Epub 2013 Jul 10. No abstract available.

PMID:
23860184
14.

Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function.

Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U.

Am J Med Sci. 2013 Mar;345(3):211-7. doi: 10.1097/MAJ.0b013e318271c012.

PMID:
23422653
15.
16.

Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study.

Dasari TW, Golwala H, Koehler M, Wayangankar S, Pakala A, Schechter E, Lozano P, Abu-Fadel MS, Latif F, Thadani U.

Am J Med Sci. 2013 May;345(5):339-42. doi: 10.1097/MAJ.0b013e31825c6951.

PMID:
23044654
17.

Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present.

Thadani U.

Cardiology. 2012;123(2):91-3. doi: 10.1159/000342799. Epub 2012 Sep 25. No abstract available.

PMID:
23018624
19.

Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.

Boden WE, Finn AV, Patel D, Peacock WF, Thadani U, Zimmerman FH.

Clin Cardiol. 2012 May;35(5):263-71. doi: 10.1002/clc.21993. Epub 2012 Apr 23. Review.

20.

Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR; ALLHAT Collaborative Research Group.

Circulation. 2011 Oct 25;124(17):1811-8. doi: 10.1161/CIRCULATIONAHA.110.012575. Epub 2011 Oct 3.

Supplemental Content

Loading ...
Support Center